Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
UST has entered multi-year agreements worth over $2 billion with three major healthcare companies, focusing on AI-driven personalization, automation, and data intelligence to enhance patient experiences and operational efficiency.
Expert.ai announced new AI-powered solutions at BioTechX Europe 2025 to improve research, clinical trial design, and regulatory processes across the pharmaceutical and life sciences industries.
Levitate has achieved HIPAA readiness and expanded its relationship-first marketing platform to healthcare providers, including dental and chiropractic practices, enabling compliant patient communication and engagement tools.
PureHealth has finalized the acquisition of a 60% stake in Hellenic Healthcare Group for €800 million, expanding its international footprint into Greece and Cyprus.
Biocare Medical and Hamamatsu have announced a strategic collaboration to deliver an integrated spatial biology solution combining staining and imaging systems for research institutions and biopharma companies.
Caris Life Sciences reported third-quarter 2025 revenue of $216.8 million, up 113% year-over-year, and raised its full-year revenue guidance to $720–$730 million.
Scott Roberts and John Czekanski have launched MOMENTUS Biopharma Consulting, a strategic firm leveraging AI and technology to support biopharma clients across the therapeutic lifecycle, according to a press release.
At the 27th Annual SoCalBio Conference, experts from RKS Design, NeuraSignal, Avenda Health, DigitalDx Ventures, and Johnson & Johnson discussed how AI can be effectively integrated into clinical workflows and reimbursement systems.
Philadelphia-based biotech LIV Process has introduced a patented technology that makes the pathogen Clostridioides difficile visible on surfaces, allowing hospitals to detect contamination invisible to the naked eye.
SYNERGEN Health has announced a strategic collaboration with Lighthouse Lab Services to deliver AI-enabled revenue cycle management solutions tailored for laboratories, aiming to improve collections, reduce denials, and enhance financial sustainability.
Cohere Health has partnered with Microsoft to integrate its AI-driven prior authorization technology into Dragon Copilot, enabling clinicians to automate care requests in real time during patient visits.
Pretty Good AI will showcase its clinic intelligence platform and AI voice technology at Thrive Summit 2025 in Nashville. The company will also host a webinar for athenaOne practices ahead of the event.
QDcme has introduced adaptive AI learning for oncologists and curated microlearning tools for primary care clinicians, marking its first anniversary and expanding its medical education offerings.
WIRobotics has received the CES 2026 Innovation Award in the Digital Health category for its WIM KIDS wearable walking assistance robot designed for children aged 4 to 15.
Royal Philips reported third-quarter earnings above expectations, supported by new AI-powered medical tools and actions to offset tariff impacts. The company recorded €531 million in adjusted EBITA and a 3% increase in sales, led by strong North American performance.
Hippocratic AI has secured $126 million in Series C funding led by Avenir Growth, valuing the company at $3.5 billion. The funds will support expansion, product development, and international growth for its generative AI healthcare agents.
Dr. Aaron Cohen-Gadol, recipient of the Vilhelm Magnus Medal, has introduced ATLAS GPT, an agentic AI platform designed to support clinical decision-making across 35 medical specialties.
AmacaThera has entered into an exclusive global licensing agreement with Pacira BioSciences worth up to $230 million to develop AMT-143, a long-acting non-opioid anesthetic for post-operative pain. Pacira will fund clinical development, manufacturing, and commercialization, with Phase 2 trials expected to start in 2026.
Subtle Medical has received EU MDR CE Marking and entered the UK market, making its AI-powered MRI enhancement software SubtleHD commercially available across the region.
SOPHiA GENETICS reported third-quarter 2025 revenue of $19.5 million, a 23% increase year-over-year, and raised its full-year revenue guidance to between $75 million and $77 million. The company highlighted strong adoption of its SOPHiA DDM platform and expanded partnerships in precision medicine.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
